Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Gliosarcoma × Drug Therapy × Clear all

Phase

Phase 2 4 Phase 1 3 Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 CNS 1

Conditions

Carcinoma, Non-Small-Cell Lung 7 Colorectal Neoplasms 6 Stomach Neoplasms 5 Breast Neoplasms 5 Pancreatic Neoplasms 4 Sarcoma 3 Ovarian Neoplasms 3 Neoplasms 3 Neoplasm Metastasis 3 Lung Neoplasms 3 Hodgkin Disease 3 Glioblastoma 3 Wilms Tumor 2 Precision Cell Immunotherapy 2 Mesothelioma, Malignant 2 Melanoma 2 Lymphoma 2 Leukemia, Myeloid, Acute 2 Head and Neck Neoplasms 2 Fallopian Tube Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Esophageal Neoplasms 2 Colonic Neoplasms 2 Cholangiocarcinoma 2 Carcinoma, Ovarian Epithelial 2 Virus Diseases 1 Vaccinia 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1

Interventions

Temozolomide 21 Radiotherapy 14 Radiation 7 Bevacizumab 6 Carboplatin 5 Everolimus 4 Erlotinib Hydrochloride 4 Carmustine 4 temsirolimus 3 Vorinostat 3 Sirolimus 3 Radiotherapy, Conformal 3 Irinotecan 3 tipifarnib 2 atezolizumab 2 Surgical Procedures, Operative 2 Radiotherapy, Intensity-Modulated 2 Gefitinib 2 Fluorodeoxyglucose F18 2 Cilengitide 2 veliparib 1 vatalanib 1 vandetanib 1 terameprocol 1 tandutinib 1 romidepsin 1 plerixafor 1 picropodophyllin 1 pembrolizumab 1 pamiparib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04528680 2025-07-31

SC9/ABX

Northwestern University

Phase 1/2 Active not recruiting

Glioblastoma, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡